Maternal characteristics during pregnancy and risk factors for positive HIV RNA at delivery: A single-cohort observational study (Brescia, Northern Italy)

BMC Public Health

Volumn 11, Issue , 2011, Pages

  Izzo, Ilaria ^a   Forleo, Maria A ^a   Casari, Salvatore ^a   Quiros Roldan, Eugenia ^a   Magoni, Michele ^a   Carosi, Giampiero ^a   Torti, Carlo ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ADULT; ARTICLE; BLOOD; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; DELIVERY; ETHNOLOGY; FEMALE; GENETICS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; ITALY; MIGRATION; PREGNANCY; PREGNANCY COMPLICATION; REGRESSION ANALYSIS; RISK FACTOR; VIROLOGY;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DELIVERY, OBSTETRIC; FEMALE; HIV SEROPOSITIVITY; HIV-1; HUMANS; ITALY; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; REGRESSION ANALYSIS; RISK FACTORS; RNA, VIRAL; TRANSIENTS AND MIGRANTS;

EID: 79951713562     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-11-124     Document Type: Article

References (12)

1. th September 2010
2. Progress toward elimination of perinatal HIV infection-Michigan 1993-2000. CDC, MMWR Morb Mortal Wkly Rep 2002 51 93 97 11892955
3. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. L Moferson JS Lambert R Stiehm, et al. N Engl J Med 1999 341 6 385 93 10.1056/NEJM199908053410601 10432323 (Pubitemid 29362511)
4. Risk factors for detectable HIV RNA at delivery among women receiving highly active antiretroviral therapy in the Women and Infants Transmission Study. IT Katz R Shapiro D Li, et al. J Acquir Immune Defic Syndr 2010 54 1 27 34 20065861
5. Factors associated with HIV RNA levels in pregnant women on non-suppressive highly active antiretroviral therapy at conception. European Collaborative Study, Antivir Ther 2010 15 1 41 9 10.3851/IMP1489 20167990
6. Antiretroviral Treatment in pregnancy: a six-year perspective on recent trends in prescriptions patterns, viral load suppression, and pregnancy outcomes. S Baroncelli E Tamburrini M Ravizza for the Italian Group on Surveillance on Antiretroviral Treatment in Pregnancy, et al. AIDS Patients Care and STDs 2009 23 7 513 20 10.1089/apc.2008.0263
7. th October 2010
8. Reproductive choice in men and women living with HIV: evidence from a large representative sample of outpatients attending French hospitals (ARS-EN12-VESPA Study). I Heard R Sitta F Lert, AIDS 2007 21 S1 77 82 10.1097/01.aids.0000255089.44297.6f 17159592
9. Trends in management and outcome of pregnancies in HIV-infected women in the UK and Ireland, 1990-2006. CL Towsend M Cortina-Borja CS Pecham PA Tookey, BJOG 2008 115 1078 1986 10.1111/j.1471-0528.2008.01706.x 18503577
10. Influence of highly active antiretroviral treatment (HAART) on risk factors for vertical HIV transmission. A Garcia-Tejedor V Maiques A Perales J Lopez-Aldeguer, Acta Obstet Gynecol Scand 2009 88 8 882 7 10.1080/ 00016340903062836 19557554
11. th October 2010
12. Does HIV-1 subtype D have higher risk of vertical transmission then other HIV subtypes? A Krivine O Launay G Firtion, et al. JID 2009 199 1533 10.1086/598481